D. Allersma

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer

W. Kloosterman, Katka Franke, J. van Zanten, 2022, Pharmaceutics.

Enantiomer‐specific pharmacokinetics of D,L‐3‐hydroxybutyrate: Implications for the treatment of multiple acyl‐CoA dehydrogenase deficiency

R. Wanders, M. Heiner-Fokkema, T. Derks, 2021, Journal of inherited metabolic disease.

Comparing doxepin cream to oral antihistamines for the treatment of itch in burn patients: A multi-center triple-blind randomized controlled trial

E. Middelkoop, M. V. van Baar, G. V. van Ramshorst, 2019, Burns Open.

Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency

J. Vockley, S. Wortmann, T. Derks, 2020, Genetics in Medicine.

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

E. Schuuring, A. V. D. Van Der Zee, J. Kosterink, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease

W. Nagengast, M. Linssen, A. Jorritsma-Smit, 2021, Pharmaceuticals.

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW

Gooitzen M van Dam, Matthijs D Linssen, Eva J Ter Weele, 2019, The Journal of Nuclear Medicine.

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles.

J. Kosterink, T. Daemen, D. Touw, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets

A. C. Eissens, H. Frijlink, P. Hagedoorn, 2022, Pharmaceutics.

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer

A. Jorritsma-Smit, Mirjam Baanstra, Bahez Gareb, 2024, Pharmaceutics.